Addressing the health and lifestyle issues of people with a mental illness: the healthy living programme

REFERENCES

• Koranyi E K. Morbidity and rate of undiagnosed physical illness in a psychiatric clinic population. Archives of General Psychiatry 1979; 36: 414–419
   PubMed Web of Science ®Google Scholar
• Berren M R, Hill K R, Merikle E, Gonzalez N, Santiago J. Serious mental illness and mortality rates. Hospital and Community Psychiatry 1994; 45: 604–605
   PubMedGoogle Scholar
• Lambert TJ R, Velakoulis D, Pantelis C. Medical co-morbidity in schizophrenia. Medical Journal of Australia 2003; 178: S67–S70
   PubMedGoogle Scholar
• Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychological Medicine 1999; 29: 697–701
   PubMed Web of Science ®Google Scholar
• Brown S, Inskip H, Barraclough B. Causes of excess mortality of schizophrenia. British Journal of Psychiatry 2000; 177: 212–217
   PubMed Web of Science ®Google Scholar
• Felker B, Yazel J, Short D. Mortality and medical co-morbidity among psychiatric patients: a review. Psychiatric Services 1996; 47: 1356–1363
   PubMed Web of Science ®Google Scholar
• Jeste D V, Gladsjo J A, Lindamer L A, Lacro J P. Medical co-morbidity in schizophrenia. Schizophrenia Bulletin 1996; 22: 413–430
   PubMed Web of Science ®Google Scholar
• Farnam C R, Zipple A M, Tyrrell W, Chittiinanda P. Health status and risk factors of people with severe and persistent mental illness. Journal of Psychosocial Nursing 1999; 37: 16–21
   PubMedGoogle Scholar
• Dixon L, Postrado L, Delahanty J, Fischer P, Lehman A. The association of medical co-morbidity in schizophrenia with poor physical and mental health. Journal of Nervous and Mental Diseases 1999; 187: 496–502
   PubMed Web of Science ®Google Scholar
• Allebreck P. Schizophrenia: a life shortening disease. Schizophrenia Bulletin 1989; 15: 81–89
   PubMedGoogle Scholar
• Wallace B, Tennant C. Nutrition and obesity in the chronic mentally ill. Australian and New Zealand Journal of Psychiatry 1998; 32: 82–85
   PubMed Web of Science ®Google Scholar
• Ryan MC M, Thakore J H. Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sciences 2002; 71: 239–257
   PubMed Web of Science ®Google Scholar
• Harris E C, Barraclough B. Excess mortality of mental disorder. British Journal of Psychiatry 1998; 173: 11–53
   PubMed Web of Science ®Google Scholar
• Elmsllie J L, Mann J I, Silverstone J T, et al. Determinants of overweight and obesity in patients with bipolar disorder. Journal of Clinical Psychiatry 2001; 62: 486–491
   PubMedGoogle Scholar
• Chamove A S. Positive short term effects of activity on behaviour in chronic schizophrenic patients. British Journal of Clinical Psychology 1986; 25: 125–133
   PubMed Web of Science ®Google Scholar
• Lubman D I, Sundram S. Substance misuse in patients with schizophrenia: a primary care guide. Medical Journal of Australia 2003; 178: S71–S75
   Google Scholar
• Hughs R, Frances R. How to help psychiatric patients stop smoking. Psychiatric Services 1995; 46: 435–436
   PubMedGoogle Scholar
• Cantor-Graae E, Nordstrom L G, McNeil T F. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophrenia Research 2001; 48: 69–82
   PubMed Web of Science ®Google Scholar
• Vieweg V, Levenston J. Medical disorders in the schizophrenic patient. International Journal of Psychiatry Medicine 1995; 25: 137–172
   PubMed Web of Science ®Google Scholar
• Byrne C, Isaacs S, Voorberg N. Assessment of the physical health needs of people with chronic mental illness: one focus for health promotion. Canada’s Mental Health 1991; 39: 7–12
   Google Scholar
• McDougall S. The effect of nutritional education on the shopping and eating habits of a small group of chronic schizophrenic patients living in the community. British Journal of Occupational Therapy 1992; 55: 62–68
   Google Scholar
• Malhotra S, McElroy S. Medical management of obesity associated with mental disorders. Journal of Clinical Psychiatry 2002; 63: S24–S32
   PubMedGoogle Scholar
• Crosse C. A meaningful day: integrating psychosocial rehabilitation into community treatment of schizophrenia. Medical Journal of Australia 2003; 178: S76–S78
   PubMedGoogle Scholar
• McKee H A, D’Arcy P F, Wilson P J. Diabetes and schizophrenia –a preliminary study. Journal of Clinical Hospital Pharmacology 1986; 11: 297–299
   PubMedGoogle Scholar
• Dixon L, Weiden P, Delahunty J, et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophrenia Bulletin 2000; 26: 903–911
   PubMed Web of Science ®Google Scholar
• Holden R J, Moody P A. Schizophrenia is a diabetic brain state: an elucidation of impaired neurometabolism. Medical Hypotheses 1994; 43: 420–435
   PubMedGoogle Scholar
• Holden R J. The estrogen connection: the etiological relationship between diabetes, cancer, rheumatoid arthritis and psychiatric disorders. Medical Hypotheses 1995; 45: 169–189
   PubMedGoogle Scholar
• Holden R J. Schizophrenia, suicide and the serotonin story. Medical Hypotheses 1995; 44: 379–391
   PubMed Web of Science ®Google Scholar
• Nasrallah H A. Factors in antipsychotic drug selection: tolerability and considerations. CNS Spectrums 2003; 8(suppl. 2)23–25
   PubMedGoogle Scholar
• Newcomer J W. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs. Journal of Clinical Psychiatry 2004; 65(suppl. 18)36–46
   PubMedGoogle Scholar
• Kornegay C J, Vasilakis-Scaramozza C, Jick H. Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database. Journal of Clinical Psychiatry 2002; 63: 758–762
   PubMed Web of Science ®Google Scholar
• Peet M. Diet, diabetes and schizophrenia: review and hypothesis. British Journal of Psychiatry 2004; 184: S102–S105
   Web of Science ®Google Scholar
• Hansen B. The metabolic syndrome. Annuals of the New York Academy of Science 1999; 892: 1–24
   PubMedGoogle Scholar
• Aquila R. Management of weight gain in patients with schizophrenia. Journal of Clinical Psychiatry 2002; 63: S33–S37
   PubMedGoogle Scholar
• Pelham T W, Campagna P D, Ritvo P G, Birnie W A. The effects of exercise therapy on clients in a psychiatric rehabilitation program. Psychosocial Rehabilitation Journal 1993; 16: 75–84
   Google Scholar
• Faulkner G, Biddle S. Exercise as an adjunct treatment for schizophrenia: a review of literature. Journal of Mental Health 1999; 8: 441–457
   Google Scholar
• Beebe L H, Tian L, Morris N, Goodwin A, Allen S S, Kuldau J. Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues in Mental Health Nursing 2005; 26: 661–676
   PubMedGoogle Scholar
• Evans S, Newton R, Higgins S. Nutritional intervention to prevent weight gain in patients commenced on olanzepine: a randomised controlled trial. Australian and New Zealand Journal of Psychiatry 2005; 39: 479–486
   PubMed Web of Science ®Google Scholar